Low ERCC1 mRNA and protein expression are associated with worse survival in cervical cancer patients treated with radiation alone

Radiotherapy and Oncology

Volumn 97, Issue 2, 2010, Pages 352-359

  Doll, Corinne M ^a   Prystajecky, Michael ^a   Eliasziw, Misha ^a   Klimowicz, Alexander C ^a   Petrillo, Stephanie K ^a   Craighead, Peter S ^a   Hao, Desiree ^a   Diaz, Roman ^a   Lees Miller, Susan P ^a   Magliocco, Anthony M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cervical cancer; ERCC1; Radiation therapy

Indexed keywords

8F1 ANTIBODY; ANTIBODY; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; HEMOGLOBIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; ARTICLE; CANCER RADIOTHERAPY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

DISEASE-FREE SURVIVAL; DNA-BINDING PROTEINS; ENDONUCLEASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UTERINE CERVICAL NEOPLASMS;

EID: 78149360164     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.08.019     Document Type: Article

References (49)

1. J. Ferlay, F. Bray, and P. Pisani GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide IARC CancerBase No. 5. version 2.0 2004 IARCPress Lyon
2. C. Vale, J.F. Tierney, L.A. Stewart Chemoradiotherapy for cervical cancer meta-analysis collaboration Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials J Clin Oncol 26 2008 5802 5812
3. J. Green, J. Kirwan, J. Tierney, C. Vale, P. Symonds, and L. Fresco Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix Cochrane Database Syst Rev 2005 [CD00225.pub2]
4. A.M. Sijbers, W.L. deLaat, R.R. Ariza, M. Biggerstaff, Y.F. Wei, and J.G. Moggs Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease Cell 86 1996 811 822
5. J.H. Enzlin, and O.D. Scharer The active site of the DNA repair endonuclease XPF-ERCC1 forms a highly conserved nuclease motif EMBO J 21 2002 2045 2053
6. O.V. Tsodikov, J.H. Enzlin, O.D. Scharer, and T. Ellenberger Crystal structure and DNA binding functions of ERCC1, a subunit of the DNA structure-specific endonuclease XPF-ERCC1 Proc Natl Acad Sci USA 102 2005 11236 11241
7. P.H.L. Gaillard, and R.D. Wood Activity of individual ERCC1 and XPF subunits in DNA nucleotide excision repair Nucleic Acids Res 29 2001 872 879
8. L. Gossage, and S. Madhusudan Current status of excision repair cross complementing-group 1 (ERCC1) in cancer Cancer Treat Rev 33 2007 565 577
9. G.R. Adair, R.L. Rolig, D. Moore-Faver, M. Zabelshansky, J.H. Wilson, and R.S. Nairn Role of ERCC1 in removal of long non-homologous tails during targeted homologous recombination EMBO J 19 2000 5552 5561
10. L.J. Niedernhofer, J. Essers, G. Weeda, B. Beverloo, J. de Wit, and M. Muijtjens The structure-specific endonuclease Ercc1-xpf is required for targeted gene replacement in embryonic stem cells EMBO J 20 2001 6540 6549
11. D.T. Bergstralh, and J. Sekelsky Interstrand crosslink repair: can XPF-ERCC1 be let off the hook? Trends Genet 24 2008 70 76
12. A. Ahmad, A.R. Robinson, A. Duensing, E. van Drunen, H.B. Beverloo, and D.B. Weisberg ERCC1-XPF endonuclease facilitates DNA double-strand break repair Mol Cell Biol 28 2008 5082 5092
13. Y. Shirota, J. Stoehlmacher, J. Brabender, Y.P. Xiang, H. Uetake, and K.D. Danenberg ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy J Clin Oncol 19 2001 4298 4304
14. R. Metzger, C.G. Leichman, K.D. Danenberg, P.V. Danenberg, H.J. Lenz, and K. Hayashi ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy J Clin Oncol 16 1998 309 316
15. H.C. Kwon, M.S. Roh, S.Y. Oh, S.H. Kim, M.C. Kim, and J.S. Kim Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer Ann Oncol 18 2007 504 509
16. M. Dabholkar, F. Bostickbruton, C. Weber, V.A. Bohr, C. Egwuagu, and E. Reed Ercc1 and Ercc2 expression in malignant-tissues from ovarian-cancer patients J Natl Cancer Inst 84 1992 1512 1517
17. U. Warnecke-Eberz, R. Metzger, F. Miyazono, S.E. Baldus, S. Neiss, and J. Brabender High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer Clin Cancer Res 10 2004 3794 3799
18. A. Handra-Luca, J. Hernandez, G. Mountzios, E. Taranchon, J. Lacau-St-Guily, and J. Soria Excision repair cross complementation group 1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carcinoma Clin Cancer Res 13 2007 3855 3859
19. H.J. Jun, M.J. Ahn, H.S. Kim, S.Y. Yi, J. Han, and S.K. Lee ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation Br J Cancer 99 2008 167 172
20. R.V.N. Lord, J. Brabender, D. Gandara, V. Alberola, C. Camps, and M. Domine Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer Clin Cancer Res 8 2002 2286 2291
21. P. Ceppi, M. Volante, S. Novello, I. Rapa, K.D. Danenberg, and P.V. Danenberg ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine Ann Oncol 17 2006 1818 1825
22. K.A. Olaussen, A. Dunant, P. Fouret, E. Brambilla, F. Andre, and V. Haddad DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy N Engl J Med 355 2006 983 991
23. C.H. Kang, B.G. Jang, D.W. Kim, D.H. Chung, Y.T. Kim, and S. Jheon The prognostic significance of ERCC1, BRCA1, XRCC1, and betaIII-tubulin expression in patients with non-small cell lung cancer treated by platinum- and taxane-based neoadjuvant chemotherapy and surgical resection Lung Cancer 68 2010 478 483
24. R.A. Britten, D. Liu, A. Tessier, M.J. Hutchison, and D. Murray ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cells Int J Cancer 89 2000 453 457
25. K.K. Khanna, and S.P. Jackson DNA double-strand breaks: signaling, repair, the cancer connection Nat Genet 27 2001 247 254
26. J.S. Rubin, and G.F. Whitmore DNA repair-deficient chinese hamster ovary cells exhibiting differential sensitivity to gamma rays under aerobic, hypoxic conditions Radiat Res 101 1985 528 534
27. D. Murray, and E. Rosenberg The importance of the ERCC1/ERCC4[XPF] complex for hypoxic-cell radioresistance does not appear to derive from its participation in the nucleotide excision repair pathway Mutat Res-DNA Repair 364 1996 217 226
28. K. Hafer, K.K. Iwamoto, Z. Scuric, and R.H. Schiestl Adaptive response to gamma radiation in mammalian cells proficient, deficient in components of nucleotide excision repair Radiat Res 168 2007 168 174
29. L. Hampson, E.S.A. El Hady, J.V. Moore, H. Kitchener, and I.N. Hampson The HPV16 E6 and E7 proteins and the radiation resistance of cervical carcinoma FASEB J 15 2001 1445
30. J. Carles, M. Monzo, M. Amat, S. Jansa, R. Artells, and A. Navarro Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with stage I to II head-and-neck cancer Int J Radiat Oncol Biol Phys 66 2006 1022 1030
31. L.J. Niedernhofer, N. Bhagwat, and R.D. Wood ERCC1 and non-small-cell lung cancer N Engl J Med 356 2007 2538 2540
32. N.R. Bhagwat, V.Y. Roginskaya, M.B. Acquafondata, R. Dhir, R.D. Wood, and L.J. Niedernhofer Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue Cancer Res 69 2009 6831 6838
33. D.T.R. Coulson, S. Brockbank, J.G. Quinn, S. Murphy, R. Ravid, and G.B. Irvine Identification of valid reference genes for the normalization of RT qPCR gene expression data in human brain tissue Bmc Mol Biol 9 2008 46
34. J. Vandesompele, K. De Preter, F. Pattyn, B. Poppe, N. Van Roy, and A. De Paepe Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes Genome Biol 3 2002 23 [RESEARCH0034. Epub.]
35. C.L. Andersen, J.L. Jensen, and T.F. Orntoft Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets Cancer Res 64 2004 5245 5250
36. C.H. Chung, J.S. Parker, K. Ely, J. Carter, Y. Yi, and B.A. Murphy Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappa B signaling as characteristics of a high-risk head and neck squamous cell carcinoma Cancer Res 66 2006 8210 8218
37. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR, the 2(T)(-delta delta C) method Methods 25 2001 402 408
38. R.L. Camp, G.G. Chung, and D.L. Rimm Automated subcellular localization, quantification of protein expression in tissue microarrays Nat Med 8 2002 1323 1327
39. F.B. Stehman, B.N. Bundy, P.J. Disaia, H.M. Keys, J.E. Larson, and W.C. Fowler Carcinoma of the cervix treated with radiation therapy-i - a multi-variate analysis of prognostic variables in the gynecologic oncology group Cancer 1991 2776 2785
40. M. Grogan, G.M. Thomas, I. Melamed, F.L.W. Wong, R.G. Pearcey, and P.K. Joseph The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix Cancer 86 1999 1528 1536
41. D. Murray, A. Macann, J. Hanson, and E. Rosenberg ERCC1/ERCC4 5′-endonuclease activity as a determinant of hypoxic cell radiosensitivity Int J Radiat Biol 69 1996 319 327
42. G.R. Simon, S. Sharma, A. Cantor, P. Smith, and G. Bepler ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer Chest 127 2005 978 983
43. K.A. Olaussen, P. Fouret, and G. Kroemer ERCC1-specific immunostaining in non-small-cell lung cancer N Engl J Med 357 2007 1559 1561
44. Z. Zheng, T. Chen, X. Li, E. Haura, A. Sharma, and G. Bepler DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer N Engl J Med 356 2007 800 808
45. Goyal S, Parikh RR, Green C, Schiff D, Moran MS, Yang Q, et al. Clinicopathologic significance of excision repair cross-complementation 1 expression in patients treated with breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 2009;May 21. Epub.
46. C. Griffin, H. de Waard, B. Deans, and J. Thacker The involvement of key DNA repair pathways in the formation of chromosome rearrangements in embryonic stem cells DNA Repair 4 2005 1019 1027
47. L. Cheng, M.R. Spitz, W.K. Hong, and Q.Y. Wei Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis Carcinogenesis 21 2000 1527 1530
48. M. Benchekroun, J. DeGraw, J. Gao, L. Sun, K. von Boguslawsky, and A. Leminen Impact of fixative on recovery of mRNA from paraffin-embedded tissue Diagn Mol Pathol 13 2004 116 125
49. M. Cobo, D. Isla, B. Massuti, A. Montes, J. Miguel Sanchez, and M. Provencio Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer JCO 2007 2747 2754